Peroral endoscopic myotomy (POEM) has emerged as a rescue treatment for recurrent or persistent achalasia after failed initial management. Therefore, we aimed to investigate the efficacy and safety of POEM in achalasia patients with failed previous intervention. We searched the MEDLINE, Embase, Cochrane, and PubMed databases using the queries “achalasia,” “peroral endoscopic myotomy,” and related terms in March 2019. Data on technical and clinical success, adverse events, Eckardt score and lower esophageal sphincter (LES) pressure were collected.The pooled event rates, mean differences (MDs) and risk ratios (RR) were calculated. A total of 15 studies with 2,276 achalasia patients were included. Overall, the pooled technical success, clinical success and adverse events rate of rescue POEM were 98.0% (95% confidence interval [CI], 96.6% to 98.8%), 90.8% (95% CI, 88.8% to 92.4%) and 10.3% (95% CI, 6.6% to 15.8%), respectively. Seven studies compared the clinical outcomes of POEM between previous failed treatment and the treatment naïve patients. The RR for technical success, clinical success, and adverse events were 1.00 (95% CI, 0.98 to 1.01), 0.98 (95% CI, 0.92 to 1.04), and 1.17 (95% CI, 0.78 to 1.76), respectively. Overall, there was significant reduction in the pre- and post-Eckardt score (MD, 5.77; p<0.001) and LES pressure (MD, 18.3 mm Hg; p<0.001) for achalasia patients with failed previous intervention after POEM. POEM appears to be a safe, effective and feasible treatment for individuals who have undergone previous failed intervention. It has similar outcomes in previously treated and treatment-naïve achalasia patients.

Objective To prepare FLIVIGSII peptide(FI peptide)and investigate its physicochemical properties and hemostatic effect in vivo and in vitro.Methods The self-assembling peptide-based hydrogels were prepared by the FI peptide mixed with water.After gross observation for the hydrogel state of the FI peptide,scanning electron microscopy(SEM)and transmission electron microscopy(TEM)were used for its microstructure,and dynamic light scattering(DLS)was performed for its size.The hemostatic effect of FI peptide after being mixed with blood samples treated with 3.8％sodium citrate was observed,and the microstructure of the blood clot was observed with SEM.CCK-8 assay and hemolysis assay were performed to verify its biocompatibility.After a rat model of hepatic parenchymal perforation and hemorrhage was established,15 female SD rats(6～8 weeks old,weighing 150 g)were randomly divided into control group,FI peptide group and fibrin sealant group.The hemostatic effect of FI peptide and prognosis was observed and analyzed after treatment in each group,and the hemostatic mechanism was also investigated.Results FI peptides were successfully prepared,and it could rapidly self-assemble into a nanofiber network hydrogel in water,and further cause formation of blood clots.SEM showed that FI peptides self-assembled to form fibrous hydrogels after mixing with water.TEM results verified that the FI peptide formed into nanofibers in a diameter of 13.70±2.31 nm after gelatinization in water,and DLS results verified that the FI peptide formed polydisperse and multi-size nanofibers in water(in a range of 148.2～208.0 nm or 575.0～807.0 nm).The fibrous hydrogel formed by the FI peptide mixed with the blood could envelop the red blood cells,thus form a physical hemostatic barrier to achieve blood clotting in seconds.FI peptide hydrogel had no cytotoxicity to normal hepatocytes(L-O2 cells)and did not cause hemolysis of red blood cells.In in vivo experiment,FI peptide quickly formed nanofiber hydrogel when in contact with blood,thus formed physical hemostasis barrier to achieve hemostasis within a few seconds(hemostasis time＜5 s).Conclusion The FI peptide exhibits a rapid and efficient hemostatic effect,indicating a promising clinical application in the hemostasia of hepatic parenchymal traumatic hemorrhage.